Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mulder KE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mulder KE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Hendriksen PA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Ulijn GA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Išerić E; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Garssen J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands.; Global Centre of Excellence Immunology, Nutricia Danone Research, 3584CT, Utrecht, the Netherlands., Verster JC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands.; Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne, VIC, 3122, Australia.
Publikováno v:
Brain, behavior, & immunity - health [Brain Behav Immun Health] 2024 May 03; Vol. 38, pp. 100792. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Autor:
Mulder KE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., van Oostrom EC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Verheul MC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Hendriksen PA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Thijssen S; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Diks MA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Kraneveld AD; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands., Garssen J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands.; Global Centre of Excellence Immunology, Nutricia Danone Research, 3584CT, Utrecht, the Netherlands., Verster JC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG, Utrecht, the Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC, 3122, Australia.
Publikováno v:
Brain, behavior, & immunity - health [Brain Behav Immun Health] 2023 Jun 30; Vol. 31, pp. 100660. Date of Electronic Publication: 2023 Jun 30 (Print Publication: 2023).
Autor:
Verster JC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC, 3122, Australia., Mulder KE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Verheul MC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., van Oostrom EC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands., Hendriksen PA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC, 3122, Australia., Scholey A; Nutrition Dietetics and Food, School of Clinical Sciences, Monash University, Clayton, VIC, 3168, Australia., Garssen J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG, Utrecht, the Netherlands.; Global Centre of Excellence Immunology, Nutricia Danone Research, 3584CT, Utrecht, the Netherlands.
Publikováno v:
Heliyon [Heliyon] 2023 Apr 05; Vol. 9 (4), pp. e15280. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).
Autor:
Breadner D; Department of Oncology, A3-924 LRCP Medical Oncology, London Regional Cancer Program, 800 Commissioners Road East, London, ON, N6A5W9, Canada. Daniel.breadner@lhsc.on.ca.; Schulich School of Medicine and Dentistry at, Western University, London, ON, Canada. Daniel.breadner@lhsc.on.ca., Loree JM; BC Cancer, Vancouver, BC, Canada., Cheung WY; Department of Oncology, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada., Gipson M; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland., Lakkunarajah S; Schulich School of Medicine and Dentistry at, Western University, London, ON, Canada., Mulder KE; Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada., Spartlin JL; Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada., Kong S; Department of Oncology, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada., Ding PQ; Oncology Outcomes, Calgary, AB, Canada.; Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada., Gill S; BC Cancer, Vancouver, BC, Canada., Welch SA; Department of Oncology, A3-924 LRCP Medical Oncology, London Regional Cancer Program, 800 Commissioners Road East, London, ON, N6A5W9, Canada.; Schulich School of Medicine and Dentistry at, Western University, London, ON, Canada.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Nov 01; Vol. 22 (1), pp. 1119. Date of Electronic Publication: 2022 Nov 01.
Autor:
Abraham AG; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Joseph K; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Spratlin JL; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Zebak S; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Alba V; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; University of Alberta, Edmonton, Alberta, Canada., Iafolla M; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Department of Medical Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada., Ghosh S; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Abdelaziz Z; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Department of Clinical Oncology, Cairo University, Cairo, Egypt., Lui A; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Paulson K; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Bedard E; Department of Thoracic Surgery, Royal Alexandra Hospital, University of Alberta, Edmonton, Alberta, Canada., Chua N; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Tankel K; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Koski S; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Scarfe A; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Severin D; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Zhu X; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., King K; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Easaw JC; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Mulder KE; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: karen.mulder@albertahealthservices.ca.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Sep; Vol. 34 (9), pp. e369-e376. Date of Electronic Publication: 2022 Jun 07.
Autor:
Kritikou E; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. e.kritikou@lacdr.leidenuniv.nl., Depuydt MAC; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. m.a.c.depuydt@lacdr.leidenuniv.nl., de Vries MR; Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. m.r.de_vries@lumc.nl.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. m.r.de_vries@lumc.nl., Mulder KE; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. kevin.evan@hotmail.com., Govaert AM; Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. a.m.govaert@lumc.nl.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. a.m.govaert@lumc.nl., Smit MD; Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. m.d.smit@lumc.nl.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. m.d.smit@lumc.nl., van Duijn J; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. a.c.foks@lacdr.leidenuniv.nl., Foks AC; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. a.c.foks@lacdr.leidenuniv.nl., Wezel A; Department of Surgery, HMC Westeinde, 2512 VA The Hague, The Netherlands. a.wezel@haaglandenmc.nl., Smeets HJ; Department of Surgery, HMC Westeinde, 2512 VA The Hague, The Netherlands. h.smeets@haaglandenmc.nl., Slütter B; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. b.a.slutter@lacdr.leidenuniv.nl., Quax PHA; Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. p.h.a.quax@lumc.nl.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. p.h.a.quax@lumc.nl., Kuiper J; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. j.kuiper@lacdr.leidenuniv.nl., Bot I; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. i.bot@lacdr.leidenuniv.nl.
Publikováno v:
Cells [Cells] 2019 Apr 09; Vol. 8 (4). Date of Electronic Publication: 2019 Apr 09.
Autor:
Loree JM; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Sha A; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Soleimani M; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Kennecke HF; Department of Oncology, Virginia Mason Medical Center, Seattle, WA., Ho MY; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Cheung WY; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Mulder KE; Department of Oncology and Faculty of Medicine and Dentistry, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Abadi S; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Spratlin JL; Department of Oncology and Faculty of Medicine and Dentistry, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Gill S; Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: sgill@bccancer.bc.ca.
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2018 Jun; Vol. 17 (2), pp. 156-163. Date of Electronic Publication: 2018 Feb 07.
Autor:
Mulder KE; Alberta: Medical Oncology (Mulder), Cross Cancer Institute, University of Alberta, Edmonton; Radiation Oncology (Doll) and Medical Oncology (Dowden), Tom Baker Cancer Centre, University of Calgary, Calgary., Ahmed S; Saskatchewan: Medical Oncology (Ahmed), Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon., Davies JD; British Columbia: Medical Oncology (Davies, Gill, Lim, McGhie) and Surgical Oncology (McFadden), BC Cancer Agency, University of British Columbia, Vancouver., Doll CM; Alberta: Medical Oncology (Mulder), Cross Cancer Institute, University of Alberta, Edmonton; Radiation Oncology (Doll) and Medical Oncology (Dowden), Tom Baker Cancer Centre, University of Calgary, Calgary., Dowden S; Alberta: Medical Oncology (Mulder), Cross Cancer Institute, University of Alberta, Edmonton; Radiation Oncology (Doll) and Medical Oncology (Dowden), Tom Baker Cancer Centre, University of Calgary, Calgary., Gill S; British Columbia: Medical Oncology (Davies, Gill, Lim, McGhie) and Surgical Oncology (McFadden), BC Cancer Agency, University of British Columbia, Vancouver., Gordon V; Manitoba: Medical Oncology (Gordon, Wong), Cancer Care Manitoba, and Surgery (Hebbard, Park), University of Manitoba, Winnipeg., Hebbard P; Manitoba: Medical Oncology (Gordon, Wong), Cancer Care Manitoba, and Surgery (Hebbard, Park), University of Manitoba, Winnipeg., Lim H; British Columbia: Medical Oncology (Davies, Gill, Lim, McGhie) and Surgical Oncology (McFadden), BC Cancer Agency, University of British Columbia, Vancouver., McFadden A; British Columbia: Medical Oncology (Davies, Gill, Lim, McGhie) and Surgical Oncology (McFadden), BC Cancer Agency, University of British Columbia, Vancouver., McGhie JP; British Columbia: Medical Oncology (Davies, Gill, Lim, McGhie) and Surgical Oncology (McFadden), BC Cancer Agency, University of British Columbia, Vancouver., Park J; Manitoba: Medical Oncology (Gordon, Wong), Cancer Care Manitoba, and Surgery (Hebbard, Park), University of Manitoba, Winnipeg., Wong R; Manitoba: Medical Oncology (Gordon, Wong), Cancer Care Manitoba, and Surgery (Hebbard, Park), University of Manitoba, Winnipeg.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2016 Dec; Vol. 23 (6), pp. 425-434. Date of Electronic Publication: 2016 Dec 21.